Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-020666
Filing Date
2023-03-22
Accepted
2023-03-22 20:39:16
Documents
2
Period of Report
2023-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
2 POA DOCUMENT poa.txt EX-24 3052
  Complete submission text file 0001209191-23-020666.txt   6295
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. /DE/ (Issuer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CALCIMEDICA, INC. 505 COAST BOULEVARD SOUTH LA JOLLA CA 92037
Business Address
Stauderman Kenneth A. (Reporting) CIK: 0001969388 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39538 | Film No.: 23754240